Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
Crossref DOI link: https://doi.org/10.1007/s00259-014-2906-4
Published Online: 2014-09-11
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kashyap, Raghava
Hofman, Michael S.
Michael, Michael
Kong, Grace
Akhurst, Timothy
Eu, Peter
Zannino, Diana
Hicks, Rodney J.
Text and Data Mining valid from 2014-09-11